BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38497715)

  • 1. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gut microbiota of esophageal squamous cell carcinoma patients.
    Cheung MK; Yue GGL; Lauw S; Li CSY; Yung MY; Ng SC; Yip HC; Kwan HS; Chiu PWY; Lau CBS
    J Gastroenterol Hepatol; 2022 Oct; 37(10):1919-1927. PubMed ID: 35816164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal and serum metabolomic signatures and gut microbiota characteristics of allergic rhinitis mice model.
    Chen Z; He S; Wei Y; Liu Y; Xu Q; Lin X; Chen C; Lin W; Wang Y; Li L; Xu Y
    Front Cell Infect Microbiol; 2023; 13():1150043. PubMed ID: 37180443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut Microbiome Differences between Gastrointestinal Cancer Patients and Healthy People].
    Li NN; Bai CM; Zhao L; Ge YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):636-645. PubMed ID: 31699194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches.
    Dhakan DB; Maji A; Sharma AK; Saxena R; Pulikkan J; Grace T; Gomez A; Scaria J; Amato KR; Sharma VK
    Gigascience; 2019 Mar; 8(3):. PubMed ID: 30698687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
    Huang X; Chen X; Wan G; Yang D; Zhu D; Jia L; Zheng J
    BMC Cancer; 2024 Feb; 24(1):245. PubMed ID: 38388357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma.
    Jiang Z; Wang J; Shen Z; Zhang Z; Wang S
    Front Cell Infect Microbiol; 2021; 11():774330. PubMed ID: 34858881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the presence of
    Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
    Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer.
    Liu F; Li J; Guan Y; Lou Y; Chen H; Xu M; Deng D; Chen J; Ni B; Zhao L; Li H; Sang H; Cai X
    Int J Biol Sci; 2019; 15(11):2381-2392. PubMed ID: 31595156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
    Cheng J; Zheng G; Jin H; Gao X
    Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics.
    Guan H; Pu Y; Liu C; Lou T; Tan S; Kong M; Sun Z; Mei Z; Qi Q; Quan Z; Zhao G; Zheng Y
    mSphere; 2021 Oct; 6(5):e0063621. PubMed ID: 34523982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal interplays between fecal metabolome and gut microbiome reveal functional signatures in cerebral ischemic stroke.
    Zhao L; Wang C; Peng S; Zhu X; Zhang Z; Zhao Y; Zhang J; Zhao G; Zhang T; Heng X; Zhang L
    J Transl Med; 2022 Oct; 20(1):459. PubMed ID: 36209079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiome combined with metabolomics reveals biomarkers and pathways in central precocious puberty.
    Huang X; Chen J; Zou H; Huang P; Luo H; Li H; Cai Y; Liu L; Li Y; He X; Xiang W
    J Transl Med; 2023 May; 21(1):316. PubMed ID: 37170084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the Gut Microbiota and Metabolomics of Seafarers after a Six-Month Sea Voyage.
    Jiang CH; Fang X; Huang W; Guo JY; Chen JY; Wu HY; Li ZS; Zou WB; Liao Z
    Microbiol Spectr; 2022 Oct; 10(5):e0189922. PubMed ID: 36197290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites.
    Luan J; Zhang F; Suo L; Zhang W; Li Y; Yu X; Liu B; Cao H
    BMC Pulm Med; 2024 Jan; 24(1):1. PubMed ID: 38166904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysbiosis of gut microbiota in patients with esophageal cancer.
    Deng Y; Tang D; Hou P; Shen W; Li H; Wang T; Liu R
    Microb Pathog; 2021 Jan; 150():104709. PubMed ID: 33378710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.